RECRUITING

Evaluation of Tasso+ Blood Self-Collection for Clinical Diagnostic Assessment of Various Biomarkers

Talk to us

Conditions

Blood Self-Collection for Clinical Diagnostic Assessments

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study aims to assess the effectiveness and reliability of the Tasso+ capillary blood self-collection device in the clinical diagnostic assessment of various biomarkers. The study will collect blood specimens using both the Tasso+ self-collection device and traditional venipuncture. The biomarker analysis results from both specimen types will be compared for correlation.

Official Title

Evaluation of Tasso+ Capillary Blood Self-Collection for Clinical Diagnostic Assessment of Various Biomarkers

Quick Facts

Study Start:2023-07-25
Study Completion:2025-07
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05852925

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:13 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Age: Participants must be 13 years of age or older.
  2. 2. Medical history: There may be no specific medical history requirements for inclusion, although participants may need to meet certain general health criteria.
  3. 3. Sample type: Participants must be willing and able to provide the human specimens needed for the study, such as blood, urine, or saliva.
  4. 4. Ability to provide consent: Participants must have the ability to provide informed consent to participate in the study, either on their own behalf if they are legally able to do so, or with the consent of a parent or guardian if they are under 18 years of age.
  5. 5. Language proficiency: Participants must be able to read and understand the language used in the study materials, such as informed consent forms and instructions for specimen collection.
  1. 1. Blind or visually impaired: Participants who are unable to see or have significant visual impairment that would make it difficult for them to participate in the study.
  2. 2. Decisionally impaired: Participants who are unable to provide informed consent due to cognitive impairment, developmental disability, or other mental health conditions that affect decision-making capacity.
  3. 3. Educationally disadvantaged: Participants who lack the education or literacy skills required to understand the study procedures or provide informed consent.
  4. 4. Hospitalized: Participants who are currently hospitalized, as they may not be able to participate in the study due to their medical condition or limited mobility.
  5. 5. Prisoners: Participants who are incarcerated in correctional facilities, as their participation may raise ethical concerns or require additional regulatory approvals.
  6. 6. Terminally ill: Participants who have a terminal illness or life-limiting condition that may affect the study results or pose additional risks to their health.

Contacts and Locations

Study Contact

Sri Bharat Madireddy, Ph.D.
CONTACT
5616504699
sri@celestamedical.com
Vanaja Reddy Bodeddula, Ph.D.
CONTACT
5619030806
vanaja@celestamedical.com

Principal Investigator

Sri Bharat Madireddy, Ph.D.
PRINCIPAL_INVESTIGATOR
American Research Labs
Vanaja Reddy Bodeddula, Ph.D.
STUDY_DIRECTOR
American Research Labs

Study Locations (Sites)

American Research Labs
Atlantis, Florida, 33462
United States

Collaborators and Investigators

Sponsor: American Research Labs

  • Sri Bharat Madireddy, Ph.D., PRINCIPAL_INVESTIGATOR, American Research Labs
  • Vanaja Reddy Bodeddula, Ph.D., STUDY_DIRECTOR, American Research Labs

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-07-25
Study Completion Date2025-07

Study Record Updates

Study Start Date2023-07-25
Study Completion Date2025-07

Terms related to this study

Additional Relevant MeSH Terms

  • Blood Self-Collection for Clinical Diagnostic Assessments